EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A role for NFIB in SOX2 downregulation and epigenome accessibility changes due to long-term estrogen treatment of breast cancer epithelial cells

Luis E Abatti, Zoe E Gillespie, Patricia Lado-Fernández, Manuel Collado, Jennifer A Mitchell iD

Biochemistry and Cell Biology · 01.01.2025 · 103 · 1-14

DOI: 10.1139/bcb-2024-0287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry and Cell Biology, erschienen am 01.01.2025. Verfasst von Luis E Abatti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Systems Biology, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: SOXB1 Transcription Factors, Breast Neoplasms, Down-Regulation, Estrogens. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ontario Ministry of Research and Innovation, Canadian Institutes of Health Research, Canada Foundation for Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Estrogen (E2) regulates the differentiation and proliferation of mammary progenitor cells by modulating the transcription of multiple genes. One of the genes that is downregulated by E2 is SOX2, a transcription factor associated with stem and progenitor cells that is overexpressed during breast tumourigenesis. To elucidate the mechanisms underlying E2-mediated SOX2 repression, we investigated epigenome and transcriptome changes following short- and long-term E2 exposure in breast cancer cells. We found that short-term E2 exposure reduces chromatin accessibility at the downstream SOX2 SRR134 enhancer, decreasing SOX2 expression. In contrast, long-term E2 exposure completely represses SOX2 transcription while maintaining accessibility at the SRR124–134 enhancer cluster, keeping it poised for reactivation. This repression was accompanied by widespread epigenome and transcriptome changes associated with commitment towards a more differentiated and less invasive luminal phenotype. Finally, we identified a role for the transcription factor NFIB in this process, suggesting it collaborates with the estrogen receptor to mediate SOX2 repression and genome-wide epigenome accessibility changes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SOXB1 Transcription FactorsBreast NeoplasmsDown-RegulationEstrogensNFI Transcription FactorsGene Expression Regulation, NeoplasticEpigenomeEpithelial CellsHumansFemaleCell Line, TumorEpigenesis, GeneticMCF-7 Cells

Stichwörter der Autor:innen

NFIBSOX2breast cancerenhancerestrogen

Substanzen

SOXB1 Transcription FactorsSOX2 protein, humanEstrogensNFI Transcription Factors

Autor:innen und Institutionen

  • Department of Cell and Systems Biology, University of Toronto, Toronto, ON, Canada.
  • Laboratory of Cell Senescence, Cancer and Aging, Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), Santiago de Compostela, Spain.
  • Department of Physiology and Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
  • Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

ORCID-Profile: Jennifer A Mitchell

Förderung

  • Ontario Ministry of Research and Innovation
  • Canadian Institutes of Health Research
  • Canada Foundation for Innovation

Zitieren

APA

Abatti, L., Gillespie, Z., Lado-Fernández, P., Collado, M., & Mitchell, J. A. (2025). A role for NFIB in SOX2 downregulation and epigenome accessibility changes due to long-term estrogen treatment of breast cancer epithelial cells. Biochemistry and Cell Biology, 103, 1-14. https://doi.org/10.1139/bcb-2024-0287

Vancouver

Abatti L, Gillespie Z, Lado-Fernández P, Collado M, Mitchell JA. A role for NFIB in SOX2 downregulation and epigenome accessibility changes due to long-term estrogen treatment of breast cancer epithelial cells. Biochemistry and Cell Biology. 2025;103:1-14. doi:10.1139/bcb-2024-0287

BibTeX
@article{Abatti2025,
  author = {Abatti, Luis E and Gillespie, Zoe E and Lado-Fernández, Patricia and Collado, Manuel and Mitchell, Jennifer A},
  title = {A role for NFIB in SOX2 downregulation and epigenome accessibility changes due to long-term estrogen treatment of breast cancer epithelial cells},
  journal = {Biochemistry and Cell Biology},
  year = {2025},
  volume = {103},
  pages = {1--14},
  doi = {10.1139/bcb-2024-0287}
}
Kostenlos starten →